Pretreatment with L-Citrulline Positively Affects the Mucosal Architecture and Permeability of the Small Intestine in a Murine Mucositis Model

Journal of Parenteral and Enteral Nutrition

Volumn 40, Issue 2, 2016, Pages 279-286

  Antunes, Maísa Mota ^a   Leocádio, Paola Caroline Lacerda ^a   Teixeira, Lílian Gonçalves ^b   Leonel, Alda Jusceline ^a   Cara, Denise Carmona ^a   Menezes, Gustavo Batista ^a   Generoso, Simone De Vasconcelos ^a   Cardoso, Valbert Nascimento ^a   Alvarez Leite, Jacqueline Isaura ^a   Correia, Maria Isabel Toulson Davisson ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b FEDERAL UNIVERSITY OF LAVRAS   (Brazil)

Author keywords

5FU; intestinal permeability; L citrulline; mucositis

Indexed keywords

ALANINE; CITRULLINE; FLUOROURACIL; HYDROPEROXIDE; MYELOPEROXIDASE;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ASSAY; FOOD INTAKE; HISTOPATHOLOGY; INTESTINE MUCOSA PERMEABILITY; LIPID PEROXIDATION; MALE; MORPHOLOGY; MOUSE; MUCOSA INFLAMMATION; NEUTROPHIL CHEMOTAXIS; NONHUMAN; OUTCOME ASSESSMENT; OXIDATIVE STRESS; PRIORITY JOURNAL; SMALL INTESTINE MUCOSA; WEIGHT CHANGE; WEIGHT REDUCTION; ANIMAL; CHEMICALLY INDUCED; DIETARY SUPPLEMENT; DISEASE MODEL; DRUG EFFECTS; INTESTINE MUCOSA; METABOLISM; MUCOSITIS; PATHOLOGY; PERMEABILITY;

ANIMALS; CITRULLINE; DIETARY SUPPLEMENTS; DISEASE MODELS, ANIMAL; FLUOROURACIL; INTESTINAL MUCOSA; MALE; MICE; MUCOSITIS; OXIDATIVE STRESS; PERMEABILITY;

EID: 84954450788     PISSN: 01486071     EISSN: 19412444     Source Type: Journal    
DOI: 10.1177/0148607114567508     Document Type: Article

References (37)

1. Boukhettala N, Ibrahim A, Aziz M, et al. A diet containing whey protein, free glutamine, and transforming growth factor-β ameliorates nutritional outcome and intestinal mucositis during repeated chemotherapeutic challenges in rats. J Nutr. 2010; 140: 799-805.
2. Nourissat A, Vassonb MP, Merrouchea Y, et al. Relationship between nutritional status and quality of life in patients with cancer. Eur J Cancer. 2008; 44: 1238-1242.
3. Herbers AH, Feuth T, Donnelly JP, Blijlevens NM,. Citrulline-based assessment score: first choice for measuring and monitoring intestinal failure after high-dose chemotherapy. Ann Oncol. 2010; 21: 1706-1711.
4. Blijlevens NMA, Lutgens LCHW, Schattenberg AVMB, Donnelly JP,. Citrulline: a potentially simple quantitative marker of intestinal epithelial damage following myeloablative therapy. Bone Marrow Transplant. 2004; 34: 193-196.
5. Sonis ST, Elting LS, Keefe D, et al. Perspectives on cancer therapy-induced mucosal injury: pathogenesis, measurement, epidemiology, and consequences for patients. Cancer. 2004; 100: 1995-2025.
6. Torres DM, Tooley KL, Butler RN, Smith CL, Geier MS, Howarth GS,. Lyprinol only partially improves indicators of small intestinal integrity in a rat model of 5-fluorouracil-induced mucositis. Cancer Biol Ther. 2008; 7 (2): 295-302.
7. Squier CA, Kremer MJ,. Biology of oral mucosa and esophagus. J Natl Cancer Inst Monogr. 2001; 29: 7-15.
8. Chiappelli F,. The molecular immunology of mucositis: implications for evidence-based research in alternative and complementary palliative treatments. Evid Based Complement Alternat Med. 2005; 2 (4): 489-494.
9. Santos RD, Viana ML, Generoso SV, Arantes RE, Davisson Correia MI, Cardoso VN,. Glutamine supplementation decreases intestinal permeability and preserves gut mucosa integrity in an experimental mouse model. JPEN J Parenter Enteral Nutr. 2010; 34: 408-413.
10. Viana ML, Santos RG, Generoso SV, Arantes RM, Correia MI, Cardoso VN,. Pretreatment with arginine preserves intestinal barrier integrity and reduces bacterial translocation in mice. Nutrition. 2010; 26 (2): 218-23.
11. Batista MA, Nicoli JR, Martins FS, et al. Pretreatment with citrulline improves gut barrier after intestinal obstruction in mice. JPEN J Parenter Enteral Nutr. 2012; 36 (1): 69-76.
12. Moinard C, Cynober L,. Citrulline: a new player in the control of nitrogen homeostasis. J Nutr. 2007; 137: 1621S-1625S.
13. Efron DT, Most D, Barbul A,. Role of nitric oxide in wound healing. Curr Opin Clin Nutr Metab Care. 2000; 3: 197-204.
14. Morris CR, Kato GJ, Poljakovic M, et al. Dysregulated arginine metabolism, hemolysis-associated pulmonary hypertension, and mortality in sickle cell disease. JAMA. 2005; 294: 81-90.
15. Barbul A, Uliyargoli A,. Use of exogenous arginine in multiple organ dysfunction syndrome and sepsis. Crit Care Med. 2007; 35: S564-S567.
16. Popovic PJ, Zeh HJ, Ochoa JB,. Arginine and immunity. J Nutr. 2007; 137: S1681-S1686.
17. Curis E, Nicolis I, Moinard C, et al. Almost all about citrulline in mammals. Amino Acids. 2005; 29: 177-205.
18. Romero MJ, Platt DH, Caldwell RB, Caldwell RW,. Therapeutic use of citrulline in cardiovascular disease. Cardiovasc Drug Rev. 2006; 24: 275-290.
19. Heys SD, Gough DB, Eremin O,. Is nutritional support in patients with cancer undergoing surgery beneficial? Eur J Surg Oncol. 1996; 22: 292-297.
20. Hickner RC, Tanner CJ, Evans CA, et al. L-citrulline reduces time to exhaustion and insulin response to a graded exercise test. Me Sci Sports Exerc. 2006; 38 (4): 660-666.
21. Osowska S, Moinard C, Neveux N, Loï C, Cynober L,. L-citrulline increases arginine pools and restores nitrogen balance after massive intestinal resection. Gut. 2004; 53: 1781-1786.
22. Osowska S, Neveux N, Nakib S, Lasserre V, Cynober L, Moinard C,. Impairment of arginine metabolism in rats after massive intestinal resection: effect of parenteral nutrition supplemented with citrulline compared with arginine. Clin Sci (Lond). 2008; 115 (5): 159-166.
23. Ferreira TM, Leonel AJ, Melo MA, et al. Oral supplementation of butyrate reduces mucositis and intestinal permeability associated with 5-fluorouracil administration. Lipids. 2012; 47: 669-678.
24. Soares PM, Mota JM, Gomes AS, et al. Gastrointestinal dysmotility in 5-fluorouracil-induced intestinal mucositis outlasts inflammatory process resolution. Cancer Chemother Pharmacol. 2008; 63: 91-98.
25. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ,. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951; 193: 265-275.
26. Generoso SV, Viana ML, Santos RG, et al. Protection against increased intestinal permeability and bacterial translocation induced by intestinal obstruction in mice treated with viable and heat-killed. Saccharomyces boulardii. Eur J Nutr. 2011; 50: 261-269.
27. Hill A, Kiss N, Hodgson B, Crowe T, Walsh A,. Associations between nutritional status, weight loss, radiotherapy treatment toxicity and treatment outcomes in gastrointestinal cancer patients. Clin Nutr. 2001; 30: 92-98.
28. Leitão RF, Ribeiro RA, Lira AM, et al. Glutamine and alanyl-glutamine accelerate the recovery from 5-fluorouracil-induced experimental oral mucositis in hamster. Cancer Chemother Pharmacol. 2008; 61 (2): 215-222.
29. Beutheu S, Ouelaa W, Guérin C, et al. Glutamine supplementation, but not combined glutamine and arginine supplementation, improves gut barrier function during chemotherapy-induced intestinal mucositis in rats. Clin Nutr. 2014; 33 (4): 694-701
30. Vokurka S, Svoboda T, Rajdl D, et al. Serum citrulline levels as a marker of enterocyte function in patients after allogeneic hematopoietic stem cells transplantation-a pilot study. Med Sci Monit. 2013; 19: 81-85.
31. Sun Z, Wang X, Andersson R,. Role of intestinal permeability in monitoring mucosal barrier function. Dig Surg. 1998; 15: 386-397.
32. Baumgart DC, Dignass AU,. Intestinal barrier function. Curr Opin Clin Nutr Metab Care. 2002; 5: 685-694.
33. Costanza AC, Di Candia AM, Mesquita ET, Villacorta H,. O intestino na insuficiência cardíaca: aspectos funcionais, imunológicos e terapêuticos. Rev SOCERJ. 2007; 20: 443-449.
34. Quirino IEP, Correia MITD, Cardoso VN,. The impact of arginine on bacterial translocation in an intestinal obstruction model in rats. Clin Nutr. 2007; 26: 335-340.
35. Maeda T, Miyazono Y, Ito K, Hamada K, Sekine S, Horie T,. Oxidative stress and enhanced paracellular permeability in the small intestine of methotrexate-treated rats. Cancer Chemother Pharmacol. 2010; 65: 1117-1123.
36. Miyazono Y, Gao F, Hone T,. Oxidative stress contributes to methotrexate-induced small intestinaltoxicity in rats. Scand J Gastroenterol. 2004; 39: 1119-1127.
37. Xavier RJ, Podolsky DK,. Unravelling the pathogenesis of inflammatory bowel disease. Nature. 2007; 448: 427-434.